M. Hohenfellner
Papers
1
Total Citations
12
H-Index
1
About
Dr. M. Hohenfellner is a leading urologic surgeon and researcher whose work centers on advancing surgical techniques for kidney cancer, with a particular focus on partial nephrectomy outcomes. Their major contributions include spearheading the landmark OpeRa trial, a prospective, randomized, multicenter study (NCT03849820) that directly compared robotic-assisted partial nephrectomy (RAPN) against open partial nephrectomy (OPN) in patients with intermediate-to-high-complexity kidney tumors. This pivotal work, published in 2025, has already garnered 12 citations, providing crucial evidence on whether robotic approaches reduce 30-day postoperative complications. Beyond this trial, Hohenfellner’s research portfolio encompasses optimizing surgical precision, minimizing morbidity, and improving oncologic control in renal surgery. Their work has shaped contemporary urologic practice by challenging traditional open approaches and offering data-driven insights into minimally invasive alternatives. Hohenfellner’s contributions are particularly valuable for clinicians and researchers navigating the evolving landscape of nephron-sparing surgery, where balancing tumor complexity with patient outcomes remains paramount. Their rigorous trial design and commitment to evidence-based surgery continue to influence treatment paradigms and inspire future investigations into robotic-assisted techniques.
Research Focus
Key Achievements
Top Papers
- 1